7.95 USD
+0.09 (+1.15%)
7.99 USD
+0.04 (+0.5%)
We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 530 industry peers in the Biotechnology industry. While KMDA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on KMDA. These ratings could make KMDA a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
In the past year KMDA had a positive cash flow from operations.
In multiple years KMDA reported negative net income over the last 5 years.
Of the past 5 years KMDA 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.42%, KMDA belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
KMDA has a Return On Equity of 7.72%. This is amongst the best in the industry. KMDA outperforms 91.51% of its industry peers.
KMDA's Return On Invested Capital of 6.67% is amongst the best of the industry. KMDA outperforms 93.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KMDA is significantly below the industry average of 18.28%.
The 3 year average ROIC (2.97%) for KMDA is below the current ROIC(6.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROIC | 6.67% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of KMDA (11.70%) is better than 91.70% of its industry peers.
In the last couple of years the Profit Margin of KMDA has declined.
KMDA's Operating Margin of 15.89% is amongst the best of the industry. KMDA outperforms 93.58% of its industry peers.
KMDA's Operating Margin has declined in the last couple of years.
KMDA has a better Gross Margin (43.75%) than 74.53% of its industry peers.
In the last couple of years the Gross Margin of KMDA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% |
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
KMDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, KMDA has more shares outstanding
Compared to 5 years ago, KMDA has more shares outstanding
Compared to 1 year ago, KMDA has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.57 indicates that KMDA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.57, KMDA is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
The Debt to FCF ratio of KMDA is 0.59, which is an excellent value as it means it would take KMDA, only 0.59 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of KMDA (0.59) is better than 95.09% of its industry peers.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
KMDA has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: KMDA outperforms 42.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 3.57 |
ROIC/WACC0.78
WACC8.52%
2.3 Liquidity
A Current Ratio of 4.02 indicates that KMDA has no problem at all paying its short term obligations.
With a Current ratio value of 4.02, KMDA perfoms like the industry average, outperforming 48.11% of the companies in the same industry.
KMDA has a Quick Ratio of 2.25. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of KMDA (2.25) is worse than 70.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.57% over the past year.
Measured over the past years, KMDA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.60% on average per year.
KMDA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.36%.
The Revenue has been growing slightly by 4.82% on average over the past years.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
Based on estimates for the next years, KMDA will show a very strong growth in Earnings Per Share. The EPS will grow by 29.48% on average per year.
KMDA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.31% yearly.
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 22.08, which indicates a rather expensive current valuation of KMDA.
Compared to the rest of the industry, the Price/Earnings ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 94.53% of the companies listed in the same industry.
KMDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.00.
Based on the Price/Forward Earnings ratio of 17.58, the valuation of KMDA can be described as rather expensive.
94.91% of the companies in the same industry are more expensive than KMDA, based on the Price/Forward Earnings ratio.
KMDA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.08 | ||
| Fwd PE | 17.58 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaply inside the industry as 97.36% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, KMDA is valued cheaply inside the industry as 94.34% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.46 | ||
| EV/EBITDA | 9.24 |
4.3 Compensation for Growth
KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KMDA has a very decent profitability rating, which may justify a higher PE ratio.
KMDA's earnings are expected to grow with 29.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.84%, KMDA has a reasonable but not impressive dividend return.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 1.20. KMDA pays more dividend than 98.68% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, KMDA pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.84% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
7.95
+0.09 (+1.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.42%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap458.56M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (66.79%)
Short Float %0.24%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.84% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)-11.86%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)2.08%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.08 | ||
| Fwd PE | 17.58 | ||
| P/S | 2.62 | ||
| P/FCF | 24.46 | ||
| P/OCF | 15.81 | ||
| P/B | 1.73 | ||
| P/tB | 1.95 | ||
| EV/EBITDA | 9.24 |
EPS(TTM)0.36
EY4.53%
EPS(NY)0.45
Fwd EY5.69%
FCF(TTM)0.33
FCFY4.09%
OCF(TTM)0.5
OCFY6.32%
SpS3.03
BVpS4.59
TBVpS4.07
PEG (NY)0.5
PEG (5Y)N/A
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROCE | 8.44% | ||
| ROIC | 6.67% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 9.66% | ||
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% | ||
| FCFM | 10.73% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
ROICexc(3y)3.77%
ROICexc(5y)N/A
ROICexgc(3y)8.9%
ROICexgc(5y)N/A
ROCE(3y)3.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.77%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 67.04% | ||
| Cap/Sales | 5.86% | ||
| Interest Coverage | 35.6 | ||
| Cash Conversion | 67.35% | ||
| Profit Quality | 91.69% | ||
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 | ||
| Altman-Z | 3.57 |
F-Score7
WACC8.52%
ROIC/WACC0.78
Cap/Depr(3y)51.55%
Cap/Depr(5y)66.64%
Cap/Sales(3y)4.62%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
EBIT growth 1Y56.49%
EBIT growth 3YN/A
EBIT growth 5Y-2.59%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y941.67%
FCF growth 3YN/A
FCF growth 5Y7.92%
OCF growth 1Y336.09%
OCF growth 3YN/A
OCF growth 5Y11.73%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
What is the valuation status for KMDA stock?
ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
How financially healthy is KAMADA LTD?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.